Adenosine-ADORA2A Promotes Ang-Induced Angiogenesis in Intrauterine Growth Restriction Placenta via the Stat3/Akt Pathway

Abstract

BACKGROUND: Abnormal placental angiogenesis is an important cause of fetal intrauterine growth restriction (IUGR), but its underlying mechanisms and therapies remain unclear. Adenosine and its mediated signaling has been reported to be associated with the development of angiogenesis. However, whether the adenosine-related signaling plays a role in modulating angiogenesis in placenta and the IUGR pregnancy outcomes remains unclear. METHODS: The angiogenesis and adenosine signaling expressions in normal and IUGR placentas were detected in different species. And the role of adenosine in regulating IUGR pregnancy outcomes was evaluated using diet-induced IUGR mouse model. Molecular mechanisms underlying adenosine-induced angiogenesis were investigated by in vitro angiogenesis assays and in vivo Matrigel plug assays. RESULTS: Here, we demonstrated poor angiogenesis and low adenosine concentration and downregulated expression of its receptor A2a (ADORA2A [adenosine A2a receptor]) in IUGR placenta. Additionally, the beneficial effects of adenosine in improving IUGR pregnancy outcomes were revealed in a diet-induced IUGR mouse model. Moreover, adenosine was found to effectively improve adenosine signaling and angiogenesis in IUGR mice placenta. Mechanistically, by using angiogenesis assays in vitro and in vivo, adenosine was shown to activate ADORA2A to promote the phosphorylation of Stat3 (signal transducer and activator of transcription 3) and Akt (protein kinase B), resulting in increased Ang (angiogenin)-dependent angiogenesis. CONCLUSIONS: Collectively, this study uncovers an unexpected mechanism of promoting placental angiogenesis by adenosine-ADORA2A signaling and advances the translation of this signaling as a prognostic indicator and therapeutic target in IUGR treatment.

Arginine Biosynthesis Mediates Wulingzhi Extract Resistance to Busulfan-Induced Male Reproductive Toxicity

“…The sample preparation procedures were according to our previously reported protocols [ 67 ]. After thawing on ice, the samples were vortexed for 2 min until fully homogenized.…”

Unlocking the adenosine receptor mechanism of the tumour immune microenvironment

“…Adenosine receptors A2AAR and A2BAR have been approved by the FDA for drug targeting of G protein-coupled receptors. The ADORA2A gene is expressed at the RNA level in various tissues ( 11 , 12 ), while the A2AAR protein is expressed only in a few tissues, with the highest levels found in the colon, caudate nucleus, and appendix ( 13 , 14 ). A2AAR protein is also present in the cerebellum, kidney and bone marrow ( 15 ).…”

Pharmacology of Adenosine Receptors: Recent Advancements

“…In fetal intrauterine growth restriction (IUGR) placenta, where abnormal angiogenesis is significant, a recent report revealed reduced adenosine concentration and downregulated expression of A 2A ARs. Furthermore, the activation of A 2A ARs in IUGR mice placenta promoted angiogenin-dependent angiogenesis through the phosphorylation of STAT3 and Akt [ 116 ]. The administration of adenosine in the diet of piglets with IUGR resulted in an increase in average birth weight and placental efficiency and promoted angiogenesis [ 117 ].…”